Congratulations! If you’re reading this, you’ve probably successfully made it through 2020. I do say probably because with the way 2020 went, I don’t want to exclude the possibility that we might by now all be zombies wandering through a postapocalyptic hellscape. But even if that were true (and certainly some days I feel as if it might be), and you are a zombie reading the latest issue of ImmunoHorizons, welcome!
It’s been a year since I became Editor-in-Chief at ImmunoHorizons, and it has been satisfying to see many of the successes. The overall goal of ImmunoHorizons (IH), as an online American Association of Immunologists (AAI) …
In this issue
On the 2021 ImmunoHorizon
